Overview
Revenue
Non-Applicable per year
Headquarters
San Francisco Bay Area, West Coast, Western US
Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell’s mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/. Xcell Biosciences, Inc. operates as a biotechnology company. The Company develops a vitro technology to capture, grow, and analyze cancer cells directly from a patient blood sample. Xcell Biosciences serves patients in the State of California. Building products that enable propagation and gene editing in challenging cell types for clinical research and cell therapy applications
